Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
May 7th, 2024 |
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2024 |
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) |
National Institutes of Health |
May 24th, 2021 |
Strengthening the Public Health Systems and Services in US-Affiliated Pacific Islands |
Centers for Disease Control OSTLTS |
March 15th, 2022 |
Research on Bat Immunology (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
February 1st, 2022 |
U.S. Consulate General Mumbai Public Affairs Section (PAS) Annual Program Statement |
US Mission to India |
June 23rd, 2021 |
High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional) |
National Institutes of Health |
June 23rd, 2021 |
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional) |
National Institutes of Health |
August 22nd, 2022 |
Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 9th, 2022 |
The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) |
National Institutes of Health |
August 22nd, 2022 |
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
January 18th, 2022 |
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
April 16th, 2021 |
Globally coordinated safety monitoring for COVID-19 vaccines |
Centers for Disease Control NCEZID |
May 7th, 2024 |
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) |
National Institutes of Health |
May 7th, 2024 |
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) |
National Institutes of Health |
March 29th, 2021 |
Partnering with National Organizations to Support Community-Based Organizations to Increase Vaccination Coverage Across Different Racial and Ethnic Adult Populations Currently Experiencing Disparities |
Centers for Disease Control NCIRD |
March 14th, 2024 |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required) |
National Institutes of Health |
May 7th, 2024 |
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 4th, 2021 |
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed) |
National Institutes of Health |
|
March 14th, 2024 |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) |
National Institutes of Health |
March 14th, 2024 |
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) |
National Institutes of Health |
May 7th, 2024 |
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required) |
National Institutes of Health |
January 25th, 2024 |
Medical Scientist Training Program (T32) |
National Institutes of Health |
June 19th, 2023 |
AHRQ/PCORI Learning Health System Small Grant Pilot Program |
Agency for Health Care Research and Quality |
May 11th, 2021 |
Improving the Health of People with Mobility Limitations and Intellectual/Developmental Disabilities through State-based Public Health Programs |
Centers for Disease Control NCBDDD |
March 7th, 2024 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
National Institutes of Health |
October 7th, 2021 |
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2024 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2024 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2024 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
May 3rd, 2021 |
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
May 3rd, 2021 |
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) |
National Institutes of Health |
May 18th, 2021 |
HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed) |
National Institutes of Health |
April 22nd, 2022 |
HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
May 3rd, 2021 |
National Initiative to Address COVID-19 Health Disparities Among Populations at High-Risk and Underserved, Including Racial and Ethnic Minority Populations and Rural Communities |
Centers for Disease Control OSTLTS |
June 21st, 2021 |
Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement |
Centers for Disease Control OSTLTS |
March 23rd, 2022 |
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 8th, 2023 |
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
National Institutes of Health |